Evidence map›Paper›PMID 20965191›Full record

ArticleGeneral and comparative endocrinology2011

Dynamic glucoregulation and mammalian-like responses to metabolic and developmental disruption in zebrafish.

Agata Jurczyk, Nicole Roy, Rabia Bajwa, Philipp Gut, Kathryn Lipson, Chaoxing Yang, Laurence Covassin, Waldemar J Racki, Aldo A Rossini, Nancy Phillips and 5 more

Abstract read
In one paragraph

Article in General and comparative endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 122 citations in OpenAlex.

  1. Treatment of overactive KScientific reports · 2025
    Trial
  2. Article
  3. Molecules (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Advances in Zebrafish for Diabetes Mellitus with Wound Model.Bioengineering (Basel, Switzerland) · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. In Vivo Toxicity Evaluation of Sugar AdulteratedMolecules (Basel, Switzerland) · 2021
    Article
  19. Hypoglycemic Activity of Aqueous Extract of Latex fromPharmaceuticals (Basel, Switzerland) · 2021
    Article
  20. Characteristics of the New Insulin-Resistant Zebrafish Model.Pharmaceuticals (Basel, Switzerland) · 2021
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Agata JurczykUniversity of Massachusetts Medical School, Diabetes Center of Excellence, 373 Plantation Street, Suite 218, Worcester, MA 01605, USA.
Nicole Roy
Rabia Bajwa
Philipp Gut
Kathryn Lipson
Chaoxing Yang
Laurence Covassin
Waldemar J Racki
Aldo A Rossini
Nancy Phillips
Didier Y R Stainier
Dale L Greiner
Michael A Brehm
Rita Bortell
Philip diIorio
University of Massachusetts Chan Medical School · USUniversity of California, San Francisco · USSacred Heart University · USWestern New England University · US

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
MECHANISMS OF PANCREATIC ISLET DEVELOPMENT IN ZEBRAFISHF32DK009743 · NIDDK · TUFTS MEDICAL CENTER · PI DIIORIO, PHILIP J · 1997 to 2000
$43k
NIDDK NIH HHS 5P30DK32520NIDDK NIH HHS F32 DK009743NIDDK NIH HHS P30 DK032520
6 · The paper itself

Abstract

Zebrafish embryos are emerging as models of glucose metabolism. However, patterns of endogenous glucose levels, and the role of the islet in glucoregulation, are unknown. We measured absolute glucose levels in zebrafish and mouse embryos, and demonstrate similar, dynamic glucose fluctuations in both species. Further, we show that chemical and genetic perturbations elicit mammalian-like glycemic responses in zebrafish embryos. We show that glucose is undetectable in early zebrafish and mouse embryos, but increases in parallel with pancreatic islet formation in both species. In zebrafish, increasing glucose is associated with activation of gluconeogenic phosphoenolpyruvate carboxykinase1 (pck1) transcription. Non-hepatic Pck1 protein is expressed in mouse embryos. We show using RNA in situ hybridization, that zebrafish pck1 mRNA is similarly expressed in multiple cell types prior to hepatogenesis. Further, we demonstrate that the Pck1 inhibitor 3-mercaptopicolinic acid suppresses normal glucose accumulation in early zebrafish embryos. This shows that pre- and extra-hepatic pck1 is functional, and provides glucose locally to rapidly developing tissues. To determine if the primary islet is glucoregulatory in early fish embryos, we injected pdx1-specific morpholinos into transgenic embryos expressing GFP in beta cells. Most morphant islets were hypomorphic, not a genetic, but embryos still exhibited persistent hyperglycemia. We conclude from these data that the early zebrafish islet is functional, and regulates endogenous glucose. In summary, we identify mechanisms of glucoregulation in zebrafish embryos that are conserved with embryonic and adult mammals. These observations justify use of this model in mechanistic studies of human metabolic disease.

Indexed as

AnimalsAnimals, Genetically ModifiedEmbryonic DevelopmentEmbryo, NonmammalianGlucoseGreen Fluorescent ProteinsIn Situ HybridizationInsulin-Secreting CellsMiceMice, Inbred BALB CPhosphoenolpyruvate Carboxykinase (GTP)PhylogenyPicolinic AcidsRNA, MessengerZebrafish3-mercaptopicolinic acidGlucoseGreen Fluorescent ProteinsPhosphoenolpyruvate Carboxykinase (GTP)Picolinic AcidsRNA, Messenger

Identifiers

PMID20965191
PMCPMC3014420
OpenAlexW2148156681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.